Peter Marks, director of the US Food and Drug Administration’s Center for Biologics Evaluation and Research, criticized the UK’s quick release of a safety notice on adverse events about Pfizer/BioNTech’s COVID vaccine, saying there was too little context for public understanding.
After reports of two frontline national health service (NHS) staff experiencing allergic reactions related to the vaccine, named BNT162b2, the...




